New antibody-drug conjugates (ADCs) in breast cancer-an overview of ADCs recently approved and in later stages of development
{{output}}
Antibody-drug conjugates (ADCs) have changed the treatment of breast cancer (BC) in more recent years. BC is a heterogenous group of malignancies with a broad range of histopathological characteristics. ADCs represent a class of therapeutics that combines an a... ...
